hydralazine and cardiovascular agents

hydralazine has been researched along with cardiovascular agents in 71 studies

Research

Studies (71)

Timeframe	Studies, this research(%)	All Research%
pre-1990	40 (56.34)	18.7374
1990's	2 (2.82)	18.2507
2000's	20 (28.17)	29.6817
2010's	9 (12.68)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Campbell, TJ	1
Ioannou, P; Talesnik, J	1
Elkayam, U; Frishman, WH; Rubin, JN; Widerhorn, J	1
Rothlin, ME	1
Harron, DW; Nicholls, DP; Shanks, RG	1
Fang, CC; Hsieh, BS; Shyu, RS; Tsai, TJ; Wu, MS; Yen, CJ	1
Craven, R	1
Gorny, D; Henrion, D; Kubis, N; Lévy, BI; Loufrani, L	1
Cohn, JN; Franciosa, JA; Taylor, AL; Worcel, M	1
KVALE, WF	1
CORCORAN, AC; PAGE, I; TAYLOR, RD	1
JOHNSON, I; MILLER, SI; MILLS, LC; MOYER, JH; SNYDER, BH	1
HERRMANN, GR; SOTO ROJAS, G	1
KORY, RC; MENEELY, GR; ROEHM, DC	1
FORD, RV; MILLER, SI; MOYER, JH	1
MOYER, JH	1
LANG, FR; SHAPERA, RP	1
ABILDSKOV, JA; BULLINGTON, RH; BURCH, GE; RAY, CT; ROMNEY, RB	1
KARLEN, WS; KLAYMAN, MI; SILBERG, NR	1
ESKWITH, IS; LINLEY, DM	1
GROLLMAN, A; SHAPIRO, AP	1
GROB, D; LANGFORD, HG	1
BILLINGS, CE; HILKER, RR; RHOADS, PS	1
LIVESAY, WR; MILLER, SI; MOYER, JH; SNYDER, HB	1
CUBBERLY, RB; LAMB, AE; WIESEL, LL	1
SHEARS, AH; SPELLER, SL; STEEVES, LC	1
DUPUY, HJ; HULL, E; SIGNORELLI, JJ	1
GALEN, WP; JOHNSON, LL	1
FRANCO, A	1
STUPPY, LJ	1
GONI, F; ORTUZAR, R; THOMSEN, P	1
ROQUE, JA	1
DENNIS, E; HUGHES, WM; MOYER, JH	1
ALVO, M; ARMAS CRUZ, A; HARNECKER, J; MELFI, M	1
MULLER, JC; ORGAIN, ES; PRYOR, WW; RAST, CL; SIEBER, HA	1
HOOBLER, SW	1
DONNELLY, GL; MUNROE, CA; ORGAIN, ES	1
SAYIL, TA	1
GRUNER, A; STURUP, H	1
HARRIS, JE	1
GRISSOM, RL; HICK, FK; KOIK, JV; MARKOVITZ, M	1
GRIGOLATO, V	1
PERRY, HM; SCHROEDER, HA	1
SCHROEDER, HA	1
FREIS, ED; JOHNSON, RL; SCHNAPER, HW	1
Kahn, J	3
Duster, T	1
Saul, S	1
Nissen, SE	1
Hoffman, S	1
Chiou, SY; Lai, GW; Lin, G; Lin, LY	1
Bibbins-Domingo, K; Fernandez, A	2
Stockbridge, NL; Temple, R	1
Adams, K; Carson, P; Cohn, JN; Ferdinand, K; Ofili, E; Olukotun, AY; Sabolinski, ML; Tam, SW; Taylor, AL; Taylor, M; Worcel, M; Yancy, CW; Ziesche, S	1
Kahn, JD	1
Bianchi, C; Hoenig, MR; Sellke, FW	1
Fullerton, SM; Goering, S; Yu, JH	1
Abrahams, Z; Francis, GS; Mullens, W; Sokos, G; Starling, RC; Tang, WH; Taylor, DO; Young, JB	1
Dries, DL; McNamara, D; Rame, JE; Sabolinski, ML; Tam, SW; Worcel, M; Wu, AH	1
Clark, M; Pan, L; Payne, J	1
Lim, WY; Woldman, S	1
Enseleit, F; Flammer, AJ; Naegele, M; Ruschitzka, F	1
Adhyaru, B; Raj, L	1
Butler, J; Hamo, CE; Papadimitriou, L	1
Wu, A	1
Brewster, LM	1
Chakrapani, M; Kamath, A; Padakanti, A; Shenoy, A	1

Reviews

8 review(s) available for hydralazine and cardiovascular agents

Article	Year
Cardiovascular drugs in pregnancy. Cardiology clinics, 1987, Volume: 5, Issue:4 Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiovascular Agents; Digoxin; Female; Humans; Hydralazine; Nitrates; Nitroprusside; Pregnancy; Pregnancy Complications, Cardiovascular	1987
How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine. Yale journal of health policy, law, and ethics, 2004,Winter, Volume: 4, Issue:1 Topics: Black or African American; Cardiovascular Agents; Commerce; Drug Approval; Drug Combinations; Drug Labeling; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Retrospective Studies; United States	2004
Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. Current drug targets, 2008, Volume: 9, Issue:5 Topics: Angiogenic Proteins; Animals; Cardiovascular Agents; Cardiovascular Diseases; Cell Hypoxia; Cell Movement; Chemokine CXCL12; Cobalt; Endothelial Cells; Gene Expression; Humans; Hydralazine; Hypoxia-Inducible Factor 1, alpha Subunit; Monocytes; Myocardial Infarction; Neovascularization, Physiologic; Oxygen; Receptors, CXCR4; Risk Factors; Signal Transduction; Stem Cell Transplantation; Stem Cells; Wound Healing	2008
Pharmacological management of chronic heart failure: old drugs, new drugs and new indications. British journal of hospital medicine (London, England : 2005), 2013, Volume: 74, Issue:2 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Digoxin; Drug Combinations; Heart Failure; Heart Failure, Systolic; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists	2013
Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments. Swiss medical weekly, 2016, Volume: 146 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Stroke Volume; Vasodilator Agents	2016
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF). Postgraduate medical journal, 2016, Volume: 92, Issue:1094 Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents	2016
Heart Failure Guidelines on Pharmacotherapy. Handbook of experimental pharmacology, 2017, Volume: 243 Topics: Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Diuretics; Drug Combinations; Heart Failure; Humans; Hydralazine; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Nitrates; Practice Guidelines as Topic; Severity of Illness Index; Stroke Volume; Tetrazoles; Valsartan; Vasodilator Agents	2017
Heart Failure. Annals of internal medicine, 2018, 06-05, Volume: 168, Issue:11 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors	2018

Trials

3 trial(s) available for hydralazine and cardiovascular agents

Article	Year
Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man. British journal of clinical pharmacology, 1983, Volume: 15, Issue:1 Topics: Adult; Blood Pressure; Cardiovascular Agents; Clonidine; Heart Rate; Humans; Hydralazine; Male; Posture; Propranolol	1983
The African-American Heart Failure Trial: background, rationale and significance. Journal of the National Medical Association, 2002, Volume: 94, Issue:9 Topics: Black or African American; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Research Design	2002
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial. Circulation, 2007, Apr-03, Volume: 115, Issue:13 Topics: Adult; Aged; Arthralgia; Biomarkers; Black or African American; Cardiovascular Agents; Cause of Death; Disease-Free Survival; Dizziness; Double-Blind Method; Drug Combinations; Heart Failure; Heart Transplantation; Hospitalization; Humans; Hydralazine; Hypotension; Isosorbide Dinitrate; Kaplan-Meier Estimate; Middle Aged; Mortality; Natriuretic Peptide, Brain; Nitric Oxide Donors; Proportional Hazards Models; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents	2007

Other Studies

60 other study(ies) available for hydralazine and cardiovascular agents

Article	Year
Recent developments in the pharmacotherapy of cardiac failure. The Medical journal of Australia, 1992, Sep-07, Volume: 157, Issue:5 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Digoxin; Diuretics; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Vasodilator Agents	1992
Platelet antiaggregatory substances inhibit arachidonic acid induced coronary constriction. Canadian journal of physiology and pharmacology, 1986, Volume: 64, Issue:4 Topics: 1-Methyl-3-isobutylxanthine; Animals; Arachidonic Acid; Arachidonic Acids; Cardiovascular Agents; Coronary Circulation; Dipyridamole; Epoprostenol; Guinea Pigs; Heart; Hydralazine; Iloprost; In Vitro Techniques; Male; Nifedipine; Perfusion; Platelet Aggregation; Rats; Rats, Inbred Strains; Vasoconstriction	1986
[Current management of left heart failure]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1987, Dec-01, Volume: 76, Issue:49 Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Catecholamines; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Hydralazine; Nitrites; Phosphodiesterase Inhibitors; Prazosin	1987
Pharmacologic agents inhibit rat mesangial cell proliferation and collagen synthesis. Journal of the Formosan Medical Association = Taiwan yi zhi, 1998, Volume: 97, Issue:7 Topics: Aminophylline; Analysis of Variance; Animals; Cardiovascular Agents; Collagen; Glomerular Mesangium; Hydralazine; Male; Nicotinic Acids; Rats; Rats, Sprague-Dawley; Ticlopidine	1998
Tailored treatments. Trends in pharmacological sciences, 2001, Volume: 22, Issue:5 Topics: Black or African American; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate	2001
Chronic hydralazine improves flow (shear stress)-induced endothelium-dependent dilation in mouse mesenteric resistance arteries in vitro. Microvascular research, 2002, Volume: 64, Issue:1 Topics: Acetylcholine; Animals; Blood Flow Velocity; Body Weight; Cardiovascular Agents; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Hydralazine; Indomethacin; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Pressure; Stress, Mechanical; Vasodilator Agents	2002
Hexamethonium and apresoline (1-hydrazinophthalazine). Proceedings of the staff meetings. Mayo Clinic, 1952, Nov-19, Volume: 27, Issue:24 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1952
[The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine]. Die Medizinische, 1952, Nov-29, Volume: 20, Issue:48 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1952
Results with oral hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the therapy of hypertension. The American journal of the medical sciences, 1953, Volume: 225, Issue:4 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
Some reactions to apresoline, hexamethonium and hydergine. Archivos del Instituto de Cardiologia de Mexico, 1952, Volume: 22, Issue:5 Topics: Cardiovascular Agents; Ergoloid Mesylates; Ergot Alkaloids; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Oxytocics; Sympatholytics	1952
Responses of the ballistocardiogram in hypertensive patients to the acute administration of apresoline, hexamethonium, veratrone, regitine and sodium amytal. Circulation, 1953, Volume: 7, Issue:3 Topics: Amobarbital; Ballistocardiography; Barbiturates; Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Phentolamine; Sympatholytics; Veratrum Alkaloids	1953
Dibenzyline: results of therapy in patients with hypertension and a comparison with hexamethonium, 1-hydrazinophthalazine and semipurified extracts of veratrum. The New England journal of medicine, 1953, Apr-02, Volume: 248, Issue:14 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Phenoxybenzamine; Sympatholytics; Veratrum; Veratrum Alkaloids	1953
Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension. A.M.A. archives of internal medicine, 1953, Volume: 91, Issue:4 Topics: Cardiovascular Agents; Hydralazine; Hypertension; Muscle Relaxants, Central; Salts; Sympatholytics	1953
Essential hypertension; treatment with hexamethonium and apresoline. United States Armed Forces medical journal, 1953, Volume: 4, Issue:6 Topics: Cardiovascular Agents; Essential Hypertension; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
A preliminary report on clinical experiences with hexamethonium and 1-hydrazinophthalazine in the treatment of diastolic hypertension. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1953, Volume: 105, Issue:4 Topics: Cardiovascular Agents; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
Death associated with hexamethonium and 1-hydrazinophthalazine (apresoline) therapy. The New England journal of medicine, 1953, Jun-25, Volume: 248, Issue:26 Topics: Cardiovascular Agents; Death; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
The use of hexemethonium chloride and 1-hydrazinophthalazine in the treatment of hypertension. Connecticut state medical journal, 1953, Volume: 17, Issue:6 Topics: Cardiovascular Agents; Chlorides; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
A critical evaluation of the hypotensive asction of hydrallazine, hexamethonium, tetraethylammonium and dibenzyline salts in human and experimental hypertension. Circulation, 1953, Volume: 8, Issue:2 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypotension; Muscle Relaxants, Central; Phenoxybenzamine; Salts; Sympatholytics; Tetraethylammonium	1953
Further observations on the effects of autonomic blocking agents in patients with hypertension. I. General systemic effects of hexamethonium, pentamethonium, and hydrazinophthalazine. Circulation, 1953, Volume: 8, Issue:2 Topics: Bis-Trimethylammonium Compounds; Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
Clinical use of hydralazine and hexamethonium in treatment of hypertension. Journal of the American Medical Association, 1953, Sep-05, Volume: 153, Issue:1 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
Treatment of hypertension with hexamethonium alone and in combination with apresoline. Texas state journal of medicine, 1953, Volume: 49, Issue:7 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
The treatment of hypertension with hexamethonium and hydrazinophthalazine (apresoline). The Brooklyn Hospital journal, 1953, Volume: 11, Issue:3 3rd Quar Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
Newer drugs in hypertension; combined effects of 1-hydrazinophthalazine (apresoline) and hexamethonium salts; a preliminary report. Treatment services bulletin. Canada. Department of Veterans' Affairs, 1953, Volume: 8, Issue:9 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Salts; Sympatholytics	1953
Hexamethonium and apresoline; their effects on ambulatory hypertensive patients. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1953, Volume: 105, Issue:11 Topics: Cardiovascular Agents; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
Outpatient treatment of hypertension with hexamethonium and apresoline. Journal of the Medical Association of the State of Alabama, 1953, Volume: 23, Issue:3 Topics: Ambulatory Care; Cardiovascular Agents; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Relaxants, Central; Outpatients; Sympatholytics	1953
[Results of treatment of arterial hypertension with hexamethonium and apresoline]. Medicina contemporanea (Lisbon, Portugal), 1953, Volume: 71, Issue:8 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1953
Hexamethonium and hydralazine hydrochloride for treatment of hypertension. California medicine, 1954, Volume: 80, Issue:3 Topics: Cardiovascular Agents; Constipation; Hexamethonium; Hydralazine; Hypertension; Hypotension, Orthostatic; Muscle Relaxants, Central; Salts; Sympatholytics	1954
[Hexamethonium, apresoline and pyretotherapy in the treatment of arterial hypertension]. Revista medica de Chile, 1954, Volume: 82, Issue:3 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hyperthermia, Induced; Muscle Relaxants, Central; Sympatholytics	1954
Hexamethonium and apresoline (L-hydrazinophthalazine) in the treatment of malignant hypertension; report of a case. Rhode Island medical journal, 1954, Volume: 37, Issue:10 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central; Sympatholytics	1954
Treatment of hypertension with oral reserpine alone and in combination with hydralazine or hexamethonium. The American journal of the medical sciences, 1955, Volume: 229, Issue:2 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypnotics and Sedatives; Muscle Relaxants, Central; Rauwolfia; Reserpine; Sympatholytics	1955
[Early results of therapy of arterial hypertension with pentolinium alone and combined with hydrazinophthalazine and Rauwolfia]. Revista medica de Chile, 1954, Volume: 82, Issue:9 Topics: Cardiovascular Agents; Hydralazine; Hypertension; Hypnotics and Sedatives; Muscle Relaxants, Central; Pentolinium Tartrate; Rauwolfia; Sympatholytics	1954
Newer drugs in the treatment of hypertension. II. Use of hexamethonium in combination with hydralazine. Circulation, 1955, Volume: 12, Issue:3 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1955
The drug treatment of severe hypertensive disease, with particular reference to hydralazine and pentapyrrolidinium. Transactions. American College of Cardiology, 1955, Volume: 5 Topics: Cardiovascular Agents; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1955
Newer drugs in the treatment of hypertension. IV. Use of reserpine, hydralazine, and pentolinium in various combinations. Journal of the American Medical Association, 1958, Apr-26, Volume: 166, Issue:17 Topics: Cardiovascular Agents; Dermatologic Agents; Hydralazine; Hypertension; Muscle Relaxants, Central; Pentolinium Tartrate; Reserpine	1958
[Hypotensen therapy of hypertension]. Turk Tip Cemiyeti mecmuasi, 1957, Volume: 23, Issue:12 Topics: Cardiovascular Agents; Hydralazine; Hypertension; Muscle Relaxants, Central; Neostigmine; Reserpine	1957
Long-term combined drug therapy in non-malignant hypertension. Acta medica Scandinavica, 1958, Mar-17, Volume: 160, Issue:3 Topics: Cardiovascular Agents; Hydralazine; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central; Reserpine	1958
CARDIOVASCULAR RENAL AGENTS AS THEY IMPINGE ON OPHTHALMIC PRACTICE. Investigative ophthalmology, 1964, Volume: 3 Topics: Antihypertensive Agents; Benzothiadiazines; Bretylium Compounds; Carbonic Anhydrase Inhibitors; Cardiovascular Agents; Diuretics; Drug Therapy; Glycerol; Guanethidine; Hexamethonium Compounds; Hydralazine; Mannitol; Mecamylamine; Methyldopa; Mineralocorticoid Receptor Antagonists; Ophthalmology; Organomercury Compounds; Pargyline; Pentolinium Tartrate; Renal Agents; Reserpine; Tetraethylammonium Compounds; Toxicology; Urea; Veratrum; Veratrum Alkaloids	1964
Hexamethonium, hydralazine and rauwolfia serpentina therapy in hypertension. The American journal of the medical sciences, 1955, Volume: 229, Issue:5 Topics: Antihypertensive Agents; Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Rauwolfia; Secologanin Tryptamine Alkaloids; Sympatholytics	1955
[Combination of hexamethonium and hydrazinophthalazine in the treatment of arterial hypertension]. L' Ospedale maggiore, 1954, Volume: 42, Issue:10 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics	1954
The use of pentolinium tartrate with and without hydralazine in the treatment of severe hypertension. The New England journal of medicine, 1955, Jun-23, Volume: 252, Issue:25 Topics: Cardiovascular Agents; Hydralazine; Hypertension; Muscle Relaxants, Central; Pentolinium Tartrate; Sympatholytics	1955
Control of hypertension by hexamethonium and 1-hydrazinophthalazine; preliminary observations. A.M.A. archives of internal medicine, 1952, Volume: 89, Issue:4 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central	1952
Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium. Circulation, 1952, Volume: 5, Issue:6 Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central	1952
Medicine. Race and reification in science. Science (New York, N.Y.), 2005, Feb-18, Volume: 307, Issue:5712 Topics: Bias; Cardiovascular Agents; Crime; Databases, Nucleic Acid; Drug Combinations; Forensic Sciences; Gene Frequency; Genetic Variation; Genetics, Medical; Heart Diseases; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Racial Groups	2005
U.S. to review drug intended for one race. The New York times on the Web, 2005, Jun-13 Topics: Black or African American; Cardiovascular Agents; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Industry; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Marketing of Health Services; Pharmacogenetics; Racial Groups; United States; United States Food and Drug Administration	2005
Misreading race and genomics after BiDil. Nature genetics, 2005, Volume: 37, Issue:7 Topics: Black or African American; Cardiovascular Agents; Drug Approval; Drug Combinations; Genomics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration	2005
Report from the Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration; June 15-16, 2005; Gaithersburg, Md. Circulation, 2005, Sep-27, Volume: 112, Issue:13 Topics: Antihypertensive Agents; Black People; Cardiovascular Agents; Drug Combinations; Drug Labeling; Epidemiologic Measurements; Heart Failure; Humans; Hydralazine; Hypertension; Nitrates; Pediatrics; Renal Agents; United States; United States Food and Drug Administration	2005
"Racially-tailored" medicine unraveled. The American University law review, 2005, Volume: 55, Issue:2 Topics: Cardiovascular Agents; Civil Rights; Delivery of Health Care; Drug Combinations; Ethics Committees, Research; Federal Government; Financing, Government; Genetic Research; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; National Institutes of Health (U.S.); Organizational Policy; Patient Rights; Pharmacogenetics; Prejudice; Racial Groups; State Government; United States	2005
Kinetics and mechanisms of cholesterol esterase inhibition by cardiovascular drugs in vitro. Indian journal of biochemistry & biophysics, 2006, Volume: 43, Issue:1 Topics: Amlodipine; Cardiovascular Agents; Enzyme Inhibitors; Hydralazine; Kinetics; Nifedipine; Octoxynol; Simvastatin; Sterol Esterase; Taurocholic Acid	2006
BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval. Annals of internal medicine, 2007, Jan-02, Volume: 146, Issue:1 Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Public Policy; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration	2007
BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective. Annals of internal medicine, 2007, Jan-02, Volume: 146, Issue:1 Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Public Policy; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration	2007
BiDil for heart failure in black patients. Annals of internal medicine, 2007, Aug-07, Volume: 147, Issue:3 Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration	2007
BiDil for heart failure in black patients. Annals of internal medicine, 2007, Aug-07, Volume: 147, Issue:3 Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration	2007
Race-based medicine and justice as recognition: exploring the phenomenon of BiDil. Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees, 2009,Winter, Volume: 18, Issue:1 Topics: Black or African American; Cardiovascular Agents; Drug Approval; Drug Combinations; Drug Design; Ethical Theory; Healthcare Disparities; Heart Failure; History, 20th Century; History, 21st Century; Humans; Hydralazine; Isosorbide Dinitrate; Social Justice; United States	2009
Exploiting race in drug development: BiDil's interim model of pharmacogenomics. Social studies of science, 2008, Volume: 38, Issue:5 Topics: Cardiovascular Agents; Drug Combinations; History, 20th Century; History, 21st Century; Humans; Hydralazine; Intellectual Property; Isosorbide Dinitrate; Pharmacogenetics; Racial Groups; United States; United States Food and Drug Administration	2008
Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure. The American journal of cardiology, 2009, Apr-15, Volume: 103, Issue:8 Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged	2009
Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy. Circulation. Heart failure, 2009, Volume: 2, Issue:6 Topics: Black or African American; Cardiovascular Agents; Double-Blind Method; Drug Combinations; Female; Gene Frequency; Genetic Predisposition to Disease; Heart Failure, Systolic; Hospitalization; Humans; Hydralazine; Immunoassay; Isosorbide Dinitrate; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Mutation; Natriuretic Peptide, Brain; Phenotype; Proportional Hazards Models; Protein Processing, Post-Translational; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Serine Endopeptidases; Treatment Outcome; United States	2009
Question: does isosorbide dinitrate/hydralazine therapy benefit systolic heart failure patients with renal insufficiency? The Journal of the Oklahoma State Medical Association, 2011, Volume: 104, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Drug Combinations; Evidence-Based Medicine; Heart Failure, Systolic; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Randomized Controlled Trials as Topic; Renal Insufficiency; Treatment Outcome	2011
Treatments for heart failure. Many therapies can be effective, but care must be individualized. Harvard heart letter : from Harvard Medical School, 2012, Volume: 23, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Cardiac Surgical Procedures; Cardiovascular Agents; Combined Modality Therapy; Defibrillators, Implantable; Health Behavior; Heart Failure; Hemodynamics; Humans; Hydralazine; Precision Medicine	2012
Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey. ESC heart failure, 2019, Volume: 6, Issue:3 Topics: Black People; Cardiovascular Agents; Cross-Sectional Studies; Databases, Pharmaceutical; Drug Combinations; Drug Prescriptions; Europe; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate	2019
Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition. Acta medica (Hradec Kralove), 2019, Volume: 62, Issue:4 Topics: Cardiovascular Agents; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged	2019